Munich, Germany

Shaonan Wang

This inventor holds 2 USPTO granted patents. Top assignee: Park Therapeutics, Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaonan Wang. Retrieved from https://idiyas.com/inventor/shaonan-wang-wkoe53do

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Shaonan Wang in Pain Management

Introduction

Shaonan Wang is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pain management through his innovative work. With a focus on the pharmaceutical applications of Cebranopadol, Wang has developed methods that enhance the efficacy of pain treatment.

Latest Patents

Wang holds 2 patents, with his latest invention focusing on the titration of Cebranopadol. This invention relates to the administration of Cebranopadol for the treatment of pain, where the drug is administered according to a specific regimen that optimizes its therapeutic effects.

Career Highlights

Shaonan Wang is currently associated with Park Therapeutics, Inc., where he continues to advance his research in pain management. His work is characterized by a commitment to improving patient outcomes through innovative drug delivery methods.

Collaborations

Wang collaborates with talented professionals in his field, including Roberta Bursi and Chiara Piana. These partnerships enhance the research and development efforts at Park Therapeutics, Inc.

Conclusion

Shaonan Wang's contributions to the field of pain management through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic approaches to pain relief.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…